These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 31907962)

  • 1. Successful secukinumab treatment of recalcitrant juvenile generalized pustular psoriasis.
    Nishida M; Takeichi T; Kono M; Imanishi A; Maekawa N; Akiyama M; Fukai K
    J Dermatol; 2020 Mar; 47(3):e77-e78. PubMed ID: 31907962
    [No Abstract]   [Full Text] [Related]  

  • 2. Palmoplantar pustulosis emerged on a case of generalized pustular psoriasis successfully treated by secukinumab.
    Honma M; Nozaki H; Hayashi K; Iinuma S; Ishida-Yamamoto A
    J Dermatol; 2019 Dec; 46(12):e468-e469. PubMed ID: 31502309
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful treatment of generalized pustular psoriasis with secukinumab: a report of two cases.
    Sun ZL; Liu ZL; Xu YY; Zhang XL; Zhang CL; Guan X
    Chin Med J (Engl); 2020 Nov; 133(24):3015-3016. PubMed ID: 33237694
    [No Abstract]   [Full Text] [Related]  

  • 4. Secukinumab is effective in the treatment of recalcitrant palmoplantar psoriasis and palmoplantar pustular psoriasis in a daily practice setting.
    Reolid A; Armesto S; Sahuquillo-Torralba A; Torres T; Feltes R; Vilarrasa E; Belinchón I; Cueva P; Rodríguez L; Romero-Maté A; Vidal D; Coto-Segura P; Herrera-Acosta E; Riera-Monroig J; Salgado L; Llamas-Velasco M; Daudén E
    J Am Acad Dermatol; 2022 Sep; 87(3):705-709. PubMed ID: 35640798
    [No Abstract]   [Full Text] [Related]  

  • 5. Skin Infiltration of Pathogenic Migratory and Resident T Cells Is Decreased by Secukinumab Treatment in Psoriasis.
    Fujiyama T; Umayahara T; Kurihara K; Shimauchi T; Ito T; Aoshima M; Otobe E; Hashizume H; Yagi H; Tokura Y
    J Invest Dermatol; 2020 Oct; 140(10):2073-2076.e6. PubMed ID: 32199992
    [No Abstract]   [Full Text] [Related]  

  • 6. Combination of secukinumab and acitretin for generalized pustular psoriasis: A case report and review of literature.
    Li J; Wang S; Li XD; Han Y
    J Int Med Res; 2024 Apr; 52(4):3000605241247702. PubMed ID: 38661102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-world data on the clinical use of secukinumab in pediatric generalized pustular psoriasis: A 48-week retrospective study.
    Ruan SF; Zhang LL; Liu Z; Lin TT; Wang HQ; Xu QY; Xiang N; Cheng B; Liu T; Ha HY; Gong T; Ji C
    J Am Acad Dermatol; 2023 Jan; 88(1):243-246. PubMed ID: 35588923
    [No Abstract]   [Full Text] [Related]  

  • 8. Infantile generalized pustular psoriasis with excellent response to secukinumab: A case report.
    Guevara BEK; Aquino JMRM; Diaz RBS; Contreras AIT; Jeng YC; Huang HY; Hsu CK; Pandita-Reyes BSB
    Exp Dermatol; 2023 Aug; 32(8):1296-1298. PubMed ID: 36847294
    [No Abstract]   [Full Text] [Related]  

  • 9. Real-world data on the use of secukinumab and acitretin in pediatric generalized pustular psoriasis.
    Miao C; Chen Y; Wang Z; Xiang X; Liu Y; Xu Z
    J Dermatol; 2023 Feb; 50(2):258-261. PubMed ID: 35983654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment with secukinumab in a patient with generalized pustular psoriasis preceded by palmoplantar lesions.
    Sawai N; Kawakami Y; Tachibana K; Nomura H; Miyake T; Yokoyama E; Hirai Y; Morizane S
    J Dermatol; 2023 Dec; 50(12):e413-e414. PubMed ID: 37577828
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful treatment of paediatric generalized pustular psoriasis with secukinumab: a case series.
    Albela H; Begum S; Leong KF
    J Dermatolog Treat; 2022 May; 33(3):1769-1773. PubMed ID: 33706651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful Use of Secukinumab in Various Scenarios of Psoriasis.
    Chhabra G; Verma P; Khunger N
    Skinmed; 2020; 18(5):274-276. PubMed ID: 33160436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination therapy of apremilast and secukinumab in patients with moderate-to-severe, recalcitrant plaque psoriasis.
    Sacchelli L; Patrizi A; Loi C; Bardazzi F
    Clin Exp Dermatol; 2019 Oct; 44(7):e243-e244. PubMed ID: 31055844
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of IL-17 and IL-17 receptor inhibitors in the management of generalized pustular psoriasis.
    Plachouri KM; Chourdakis V; Georgiou S
    Drugs Today (Barc); 2019 Sep; 55(9):587-593. PubMed ID: 31584575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of a 3-year-old girl with generalized pustular psoriasis using secukinumab monotherapy.
    Zhu H; Song P; Du D; Tian H
    Pediatr Dermatol; 2021 Sep; 38(5):1366-1367. PubMed ID: 34515373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of refractory juvenile generalized pustular psoriasis with secukinumab monotherapy: A case report and review of published work.
    Ho PH; Tsai TF
    J Dermatol; 2018 Nov; 45(11):1353-1356. PubMed ID: 30230584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid and sustained response of acute generalized pustular psoriasis of von Zumbusch to Secukinumab.
    Wu X; Yan T; Han C; Ma L; Zeng L; Chen X; Zhang Z
    J Eur Acad Dermatol Venereol; 2023 Mar; 37(3):e338-e341. PubMed ID: 36165592
    [No Abstract]   [Full Text] [Related]  

  • 18. Transcriptomic response of peripheral blood mononuclear cells to secukinumab in an 8-year-old boy with juvenile generalized pustular psoriasis.
    Hou PC; Aala W; Lee YR; Guevara BEK; Chen PC; McGrath JA; Hsu CK
    J Eur Acad Dermatol Venereol; 2022 May; 36(5):e378-e381. PubMed ID: 35023595
    [No Abstract]   [Full Text] [Related]  

  • 19. IL-17A inhibition by secukinumab induces early clinical, histopathologic, and molecular resolution of psoriasis.
    Krueger JG; Wharton KA; Schlitt T; Suprun M; Torene RI; Jiang X; Wang CQ; Fuentes-Duculan J; Hartmann N; Peters T; Koroleva I; Hillenbrand R; Letzkus M; Yu X; Li Y; Glueck A; Hasselberg A; Flannery B; Suárez-Fariñas M; Hueber W
    J Allergy Clin Immunol; 2019 Sep; 144(3):750-763. PubMed ID: 31129129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Refractory generalized pustular psoriasis responsive to a combination of adalimumab and acitretin.
    Gallo E; Llamas-Velasco M; Daudén E; García-Diez A
    Int J Dermatol; 2013 Dec; 52(12):1610-1. PubMed ID: 22834488
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.